Breaking
Minor ScienceScience (INT)

Are T cell ‘engagers’ the next big thing in autoimmune disease treatment?

Engineered antibodies may produce remissions and offer safety benefits over cell therapies that have killed patients

Read the full story at Science ↗

ImpactMinor
Publishedunknown
AuthorMitch Leslie
MoreLess
Impact score18/100
RatingProbability of 53%.
RegionsGlobal
Retrievedvia rdf
ClassifiedWed, 18 Nov 2026 21:01:31 GMT by classifier